BACKGROUND: Neonatal renal vein thrombosis is the most common vascular condition in the newborn kidney, which could lead to serious complication in infants.
Introduction
Renal vein thrombosis is a rare condition in neonates, usually as a consequence of perinatal asphyxia, maternal diabetes mellitus, hypovolemia, hyperosmolarity and coagulopathies. Less often the cause of renal vein thrombosis is congenital heart disease, disseminated coagulopathy, prematurity and infection. External risk factors include central arterial and venous catheters. Neonates are most susceptible age group for renal vein thrombosis; premature infants are a most susceptible neonatal group.
Neonates are most susceptible for renal vein thrombosis due to the physiology of neonatal hemostasis and lower levels of anticoagulants also low levels of fibrinolytic components. The prevalence is 2.2 per 100,000 lives and around 0.5 per 1000 newborn babies treated in NICU. The prevalence of inferior vena cava thrombosis in neonates is the main symptoms are gross hematuria, papabile abdominal mass due to enlarged kidney and thrombocytopenia.
Diagnosis is suspected based on specific symptoms, ultrasonography and additional imaging studies such as venography, CT and MR urography confirm the diagnosis. Aetiology of hypercoagulable state should be searched for and treated. Inherited prothrombotic anomalies have been reported in association with neonatal renal vein thrombosis. Signs and symptoms of acute kidney injury should be monitored, and long-term follow up is mandatory. We present a patient with multiple entities in the aetiology of non-catheter induced renal and vena cava thrombosis in a neonate.
Case report
We report a case of the unilateral renal vein and inferior vena cava thrombosis, presented with gross hematuria and thrombocytopenia in a neonate. The neonate was a macrosomic male, born to a mother with hyperglycemia in pregnancy. The family history was negative for coagulopathies. He was born in 40 th -week gestation with perinatal asphyxia, Apgar scores were 6/7/7. The baby was large for gestational age; the birth weight was 5270 gr. He was plethoric, had hemoconcentration, polycythemia and had signs early neonatal sepsis (leukocytosis, thrombopenia) with massive hematuria. Fluid management and antibiotic treatment were started. Initial treatment included broad-spectrum antibiotics and anticoagulant therapy, with careful attention to fluid balance and nutrition. Protein C and antithrombin III activity were normal for the age. Thrombophilic genes were tested, and heterozygosity of FBG 455 G/A, MTHFR C677T and MTRR A66G polymorphisms was found. Mutations causing arterial and thrombotic anomalies were tested. Heterozygous mutation C677T was found in the methylene tetra hydro folate reductase gene (MTHFR), a heterozygous mutation in the LTA and 455 G>A in the B-fibrinogen gene were found.
The child is being managed conservatively. Anticoagulant therapy continued with subcutaneous low molecular mass heparin (LMWH) twice a day. Laboratory tests of kidney function showed a transient rise in serum creatinine and urea, proteinuria, and hematuria. Inflammatory parameters gradually normalised and the subsequent blood culture was negative. 
Discussion
We present a rare case of non-catheter induced inferior cava and renal vein thrombosis in a neonate. Factors predisposing this neonate to RVT include maternal diabetes, early onset infection and complicated labour. The neonate was with no family history of thrombotic disorders or fetal losses, although the child was found to have prothrombotic risk factors.
Figure 4: Small right kidney and compensatory hypertrophied left kidney, five months after birth
Neonates are prone to thrombosis in comparison to other age groups. This is because they have decreased levels of anticoagulants and fibrinolytic components. Factors predisposing to neonatal venous thrombosis are genetic and environmental. Maternal factors predisposing vein thrombosis in neonates are maternal hyperglycemia and diabetes, preeclampsia, chorioamnionitis and autoimmune diseases. Early neonatal infection, perinatal asphyxia, hypovolemia and hemoconcentration due to dehydration, polycythemia, hypercoagulability lead to renal vein thrombosis [1] . The most important cause is central arterial and venous catheters, especially umbilical venous catheterisation, reporting 75-95% of thrombotic events were catheter-related [2] .
A Dutch study refers to 66% of all thrombi in catheter-induced thrombosis was found in the inferior vena cava, but they didn't find inferior vena cava thrombi in the non-catheter related thrombosis [3] . Studies reporting non-catheter induced inferior vena cava thrombosis are rare and usually report an association with extensive renal vein thrombosis, inferior vena cava anomalies or external pressure. Inherited prothrombotic anomalies have been reported in association with neonatal renal vein thrombosis. Studies report prothrombic anomalies associated with renal vein thrombosis but less often with inferior vena cava thrombosis [4] . Our patient had a rare set of genetic and external factors leading to renal vein thrombosis but also inferior vena cava thrombosis.
Symptoms usually include gross hematuria, thrombopenia, palpable abdominal mass and renal failure. They frequently overlap with the signs and symptoms of neonatal infection and shock. Clinicians need to monitor closely to prevent renal damage. The diagnosis is suspected on renal ultrasonography (showing renal enlargement) but proven with computed tomography or magnetic urography and radioisotope scans [5] [6] . Treatment of neonatal vein thrombosis remains controversial, and the benefits and the possible side effects need to be measured. Surgical intervention is not indicated in the early phases of renal vein thrombosis [7] . Thrombectomy is rarely possible due to the small blood vessel calibre. Treatment modalities include thrombolysis using heparin, urokinase and recombinant plasminogen activator (r-tPA) [ In conclusion, in this work, we present a patient with multiple entities in the aetiology of noncatheter induced renal and vena cava thrombosis in a neonate. Clinicians should suspect renal vein thrombosis in neonates when presented with early postnatal gross hematuria, palpable abdominal mass and thrombopenia. Measures aimed at prevention of end-stage renal disease must be overtaken because of its poor outcome despite the anticoagulant treatment used.
